Latest news
THE LUSTGARTEN FOUNDATION AND BREAK THROUGH CANCER ANNOUNCE NEW CLINICAL TRIAL EVALUATING KRAS-TARGETED IMMUNOTHERAPY STRATEGY FOR PANCREATIC CANCER - PR NewswirePR Newswire · Mon, 10 Aug 2026 13:50:00 GMT17th Annual Lustgarten Foundation Westchester Walk - Hudson Valley PressHudson Valley Press · Wed, 05 Aug 2026 04:03:40 GMT